Non-Hfe iron overload: Is phlebotomy the answer?

QR Code

Non-Hfe iron overload: Is phlebotomy the answer?

Non-Hfe Iron Overload: Is Phlebotomy the Answer?Iron is an essential factor for life, however a physiologically optimal balance is critical. In this article we explore the role of iron as a co-factor in a range of chronic liver diseases and how it may contribute to the development of liver injury, f...

Full description

Bibliographic Details
Main Authors:	Hazeldine, S., Trinder, D., Olynyk, John
Format:	Journal Article
Published:	Current Science, Inc 2013
Online Access:	http://hdl.handle.net/20.500.11937/38540

Similar Items

Iron overload
by: Siah, C., et al.
Published: (2005)

Iron-overload-related disease in HFE hereditary hemochromatosis
by: Allen, K., et al.
Published: (2008)

Letter: Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials
by: Delatycki, M., et al.
Published: (2015)

The Role of Hfe in Transferrin-Bound Iron Uptake by Hepatocytes
by: Chua, A., et al.
Published: (2008)

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial
by: Ong, S., et al.
Published: (2017)

Predicting Iron Overload in Hyperferritinemia
by: Olynyk, John, et al.
Published: (2009)

Brain transcriptome perturbations in the Hfe -/- mouse model of genetic iron loading
by: Johnstone, D., et al.
Published: (2012)

Diagnosing and preventing iron overload
by: Ramanathan, G., et al.
Published: (2017)

Hereditary hemochromatosis in the post-HFE era
by: Olynyk, John, et al.
Published: (2008)

Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests
by: Adris, N., et al.
Published: (2018)

Assessing iron overload: Are we there yet?
by: Kruger, P., et al.
Published: (2012)

Reply: Does the death knell toll for phlebotomy in NAFLD?
by: Adams, Leon, et al.
Published: (2015)

Effects of HFE gene mutations and alcohol on iron status, liver biochemistry and morbidity
by: Olynyk, John, et al.
Published: (2011)

Liver oxidative stress, apoptosis, and autophagy are increased in a mouse model of iron overload
by: Chua, A., et al.
Published: (2017)

Infection control in Phlebotomy
by: Thandar Soe, Sumaiyah Jamaludin
Published: (2016)

Natural history and management of HFE hemochromatosis
by: Gan, E., et al.
Published: (2011)

Noncitrus Fruits as Novel Dietary Environmental Modifiers of Iron Stores in People With or Without HFE Gene Mutations
by: Milward, E., et al.
Published: (2008)

The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis
by: Gurrin, L., et al.
Published: (2008)

Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk
by: Johnstone, D., et al.
Published: (2012)

HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
by: Trinder, D., et al.
Published: (2008)

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial
by: Adams, L., et al.
Published: (2015)

Liver and serum iron – discrete regulators of hepatic hepcidin expression
by: Chua, A., et al.
Published: (2011)

The regulation of cellular iron metabolism
by: Chua, A., et al.
Published: (2007)

High iron and transferrin saturation levels are associated with increased risks of non-skin cancers in women
by: Chua, A., et al.
Published: (2014)

Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis
by: Sherrington, C., et al.
Published: (2006)

Liver iron transport
by: Graham, R., et al.
Published: (2007)

HFE gene polymorphisms in Malays
by: Jatta, Francis
Published: (2020)

Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron
by: Graham, R., et al.
Published: (2008)

Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)
by: Ong, S., et al.
Published: (2015)

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
by: Osborne, N., et al.
Published: (2010)

Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study
by: Davis, T., et al.
Published: (2008)

Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs
by: Ferguson, C., et al.
Published: (2015)

Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes
by: Chua, A., et al.
Published: (2016)

Plasma iron and iron delivery to the tissues
by: Graham, Ross, et al.
Published: (2012)

Iron overload in anaemia with underlying haemoglobin constant spring in an antenatal mother in primary care
by: Thew, Hui Zhu, et al.
Published: (2024)

Iron overload in anaemia with underlying haemoglobin constant spring in an antenatal mother in primary care
by: Thew, Hui Zhu, et al.
Published: (2024)

Directions for clinical practice improvement in HFE gene mutation testing
by: Gillett, M., et al.
Published: (2007)

Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age
by: Shi, Z., et al.
Published: (2009)

Brain Changes in Iron Loading Disorders
by: Milward, E., et al.
Published: (2012)

Method overloading and overriding
by: Shaikh, Muniba, et al.
Published: (2011)